Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Monneret

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Journal of Medicinal Chemistry|May 9, 1997
Preparation and anti-HIV activity of N-3-substituted thymidine nucleoside analogsD R Adams, C Perez, M Maillard, et al.
Anti-Cancer Drug Design|September 1, 1995
Prodrugs of anthracycline antibiotics suited for tumor-specific activationM Azoulay, J C Florent, C Monneret, et al.
Journal of Medicinal Chemistry|May 23, 2000
Synthesis and evaluation of "AZT-HEPT", "AZT-pyridinone", and "ddC-HEPT" conjugates as inhibitors of HIV reverse transcriptaseR Pontikis, V Dollé, J Guillaumel, et al.
Anti-Cancer Drug Design|July 16, 1999
Application of the ADEPT strategy to the MDR resistance in cancer chemotherapyS Desbene, H D Van, S Michel, et al.
Journal of Medicinal Chemistry|September 11, 1998
Prodrugs of anthracyclines for use in antibody-directed enzyme prodrug therapyJ C Florent, X Dong, G Gaudel, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Journal of Medicinal Chemistry|May 9, 1997
Preparation and anti-HIV activity of N-3-substituted thymidine nucleoside analogsD R Adams, C Perez, M Maillard, et al.
Anti-Cancer Drug Design|September 1, 1995
Prodrugs of anthracycline antibiotics suited for tumor-specific activationM Azoulay, J C Florent, C Monneret, et al.
Journal of Medicinal Chemistry|May 23, 2000
Synthesis and evaluation of "AZT-HEPT", "AZT-pyridinone", and "ddC-HEPT" conjugates as inhibitors of HIV reverse transcriptaseR Pontikis, V Dollé, J Guillaumel, et al.
Anti-Cancer Drug Design|July 16, 1999
Application of the ADEPT strategy to the MDR resistance in cancer chemotherapyS Desbene, H D Van, S Michel, et al.
Journal of Medicinal Chemistry|September 11, 1998
Prodrugs of anthracyclines for use in antibody-directed enzyme prodrug therapyJ C Florent, X Dong, G Gaudel, et al.
Pageof 6